DAR vs BIOX vs CF vs PGEN

For growth investors, CF Industries Holdings, Inc.

(CF) is the stronger pick with 19. 3% revenue growth year-over-year, versus -36. 9% for Precigen, Inc. (PGEN). CF Industries Holdings, Inc. (CF) offers the better valuation at 12. 8x trailing P/E (7. 8x forward), making it the more compelling value choice. Analysts rate Darling Ingredients Inc. (DAR) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CF Industries Holdings, Inc.

(CF) is the cheapest at 12. 8x versus Darling Ingredients Inc. at 161. 9x. On forward P/E, CF Industries Holdings, Inc. is actually cheaper at 7. 8x.

Over the past 5 years, CF Industries Holdings, Inc.

(CF) delivered a total return of +126. 0%, compared to -96. 9% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: DAR returned +345. 6% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CF Industries Holdings, Inc.

(CF) is the lower-risk stock at -0. 69β versus Bioceres Crop Solutions Corp. 's 1. 89β — meaning BIOX is approximately -373% more volatile than CF relative to the S&P 500. On balance sheet safety, Precigen, Inc. (PGEN) carries a lower debt/equity ratio of 14% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CF Industries Holdings, Inc.

(CF) is pulling ahead at 19. 3% versus -36. 9% for Precigen, Inc. (PGEN). On earnings-per-share growth, the picture is similar: CF Industries Holdings, Inc. grew EPS 33. 1% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CF Industries Holdings, Inc.

(CF) is the more profitable company, earning 20. 5% net margin versus -32. 2% for Precigen, Inc. — meaning it keeps 20. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CF leads at 33. 4% versus -34. 4% for PGEN. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, CF Industries Holdings, Inc.

(CF) trades at 7. 8x forward P/E versus 14. 5x for Darling Ingredients Inc. — 6. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PGEN: 42. 5% to $6. 00.

In this comparison, CF (1.

7% yield) pays a dividend. DAR, BIOX, PGEN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CF Industries Holdings, Inc.

(CF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 69), 1. 7% yield, +325. 8% 10Y return). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CF: +325. 8%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (DAR (Consumer Defensive) and BIOX (Basic Materials) and CF (Basic Materials) and PGEN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: DAR is a mid-cap quality compounder stock; BIOX is a small-cap quality compounder stock; CF is a mid-cap high-growth stock; PGEN is a small-cap quality compounder stock. CF pays a dividend while DAR, BIOX, PGEN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.